Delivery Order SPE2DB24D2205-SPE2DB25FDTDC

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,250.23 firm-fixed-price delivery order is for the procurement of OPZELURA 1.5% cream, a prescription pharmaceutical product. The award has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,756.15 delivery order is for OPZELURA 1.5% CREAM 60GM, a medical supply product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,217.78 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a completion date of November 27, 2024 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $7,703.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OPZELURA 1.5% Cream in 60-gram units, with a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $15,637.09 and a period of performance ending on September 25, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,094.53 Firm Fixed Price Delivery Order contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a completion date of September 25, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,187.36 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,078.49 firm fixed price delivery order is for OPZELURA 1.5% Cream, a 60 gram prescription medication. The contract has an ultimate completion date of December 3, 2024 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of OPZELURA 1.5% cream, a pharmaceutical product. The $2,166.89 firm fixed-price delivery order has a completion date of November 3, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a...
This federal contract award is for $8,948.52 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Opzelura 1.5% Cream in 60 gram units, with a period of performance through October 29, 2024. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTDC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,555.32 contract is for the delivery of OPZELURA 1.5% Cream, a prescription pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This award was made without any set-aside designation, indicating open competition.

Generated 1/23/25, 9:41 AM